Indeed, our results revealed that PAH-PASMCs exhibited elevated EP300 and NRP1 expression, along with increased global H3K27ac levels, compared with FD-PASMCs (Supplementary Figure S3). This evidence concerns the gene NRP1 and pulmonary arterial hypertension.